Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2020 08:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction

SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
May 08, 2020 07:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Reports First Quarter 2020 Financial Results

SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
April 30, 2020 16:05 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020

SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
April 22, 2020 08:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces Filing of Form S-3 Shelf Registration Statement

SAN DIEGO, April 22, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
April 06, 2020 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction

SAN DIEGO, April 06, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
March 16, 2020 16:05 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results

SAN DIEGO, March 16, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
March 10, 2020 16:05 ET | Source: CV Sciences, Inc.

CV SCIENCES, INC. RESCHEDULES FULL YEAR 2019 RESULTS CONFERENCE CALL TO MARCH 16, 2020

SAN DIEGO, March 10, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
February 26, 2020 08:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020

SAN DIEGO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
January 23, 2020 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales

Refreshed Website Guides Visitors on their Hemp CBD Journey with Multimedia Educational Resources, In-Depth Product Information and Improved Shopping Tools Company Well Positioned to Drive Rapid...
January 21, 2020 08:45 ET | Source: CV Sciences, Inc.

Farmers Insurance Open Selects +PlusCBD™ Oil as Their First-Ever CBD Sponsor

SAN DIEGO, Jan. 21, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right